QIAGEN NV EO -,01/ NL0015001WM6 /
| 06/06/2024 08:16:07 | Chg. +0.800 | Volume | Bid18:21:44 | Ask18:21:44 | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 40.845EUR | +2.00% | 0 Turnover: 0.000 |
40.990Bid Size: 80 | 41.335Ask Size: 13 | 9.39 bill.EUR | - | - |
GlobeNewswire
05/06
QIAGEN launches digital PCR Assay Design Tool for QIAcuity, expands customization capabilities of it...
GlobeNewswire
03/06
QIAGEN expands QIAstat-Dx syndromic testing menu in the U.S. with launch of molecular test to improv...
GlobeNewswire
30/05
QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global...
GlobeNewswire
30/05
QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global...
GlobeNewswire
29/05
QIAGEN launches new library preparation kit, facilitating multiomic studies and advancing precision ...
GlobeNewswire
14/05
QIAGEN receives European IVDR certification for QIAGEN Clinical Insight Interpret, its medical devic...
GlobeNewswire
13/05
QIAGEN receives FDA clearance for QIAstat-Dx respiratory syndromic testing panel for fast and accura...
GlobeNewswire
07/05
QIAGEN partners with FBI to develop digital PCR assay for QIAcuity for use in forensics
GlobeNewswire
07/05
Invizyne Technologies Expands Leadership Team Ahead of Proposed Offering and Listing on Nasdaq
GlobeNewswire
07/05
Invizyne Technologies Expands Leadership Team Ahead of Proposed Offering and Listing on Nasdaq
GlobeNewswire
02/05
QIAGEN enhances bioinformatics workflows with new secondary analysis solution for oncology and inher...
GlobeNewswire
29/04
QIAGEN reports results for Q1 2024 ahead of outlook, on track to achieve full-year 2024 guidance
GlobeNewswire
25/04
deepull unveils 1 hour, direct-from-blood multiplex PCR test for 95% of sepsis-causing pathogens at ...
GlobeNewswire
24/04
QIAGEN expands tuberculosis portfolio with new NGS Panel to support real-time surveillance and comba...
GlobeNewswire
18/04
deepull appoints Kimberle Chapin, MD, as Chief Medical Officer and Wade Stevenson as Chief Marketing...
GlobeNewswire
03/04
QIAGEN strengthens its portfolio for cancer research, showcasing latest product launches at AACR Ann...
GlobeNewswire
25/03
QIAGEN introduces QIAstat-Dx Analyzer 2.0 with remote test results access, enhancing collaboration a...
GlobeNewswire
18/03
QIAGEN partners with International Panel Physicians Association to increase awareness of tuberculosi...
GlobeNewswire
27/02
QIAGEN launches AI-derived biomedical knowledge base to accelerate data-driven drug discovery
GlobeNewswire
27/02
QIAGEN earns ACT Label for new eco-friendlier QIAwave products and achieves first My Green Lab Plati...
